NantHealth Reports 2018 Fourth-Quarter, Full-Year Financial Results

Go back to NantHealth Reports 2018 Fourth-Quarter, Full-Year Financial Results

NantHealth (NH) PT Lowered to $2.30 at Cowen

April 1, 2019 1:24 PM EDT

Cowen analyst Charles Rhyee lowered the price target on NantHealth (NASDAQ: NH) to $2.30 (from $2.70) while maintaining a Outperform rating.

slight miss on revenuegrowth in GPS tests ordered 'encouraging'... More

NantHealth (NH) Tops Q4 EPS by 1c, Revenues Miss

March 28, 2019 4:25 PM EDT

NantHealth (NASDAQ: NH) reported Q4 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $22.9 million versus the consensus estimate of $23.07 million.

Total Revenue in Q4 was $22.9 MillionSaaS revenue of $17.3 million in Q4, up 9% from... More